Nocion, chasing GSK, pulls in $62M for chronic cough drug
BioPharma Dive,
Investors have poured $62 million into a biotechnology startup developing a drug to treat chronic cough.
Investors have poured $62 million into a biotechnology startup developing a drug to treat chronic cough.
Investors have poured $62 million into a biotechnology startup developing a drug to treat chronic cough.